Table: begin end state 1 20 non-cytoplasmic 21 43 transmembrane 44 49 cytoplasmic 50 82 transmembrane 83 92 non-cytoplasmic 93 113 transmembrane 114 122 cytoplasmic 123 140 transmembrane 141 167 non-cytoplasmic 168 188 transmembrane 189 199 cytoplasmic 200 228 transmembrane 229 247 non-cytoplasmic 248 269 transmembrane 270 288 cytoplasmic 289 307 transmembrane 308 324 non-cytoplasmic 325 359 transmembrane 360 377 cytoplasmic 378 406 transmembrane 407 407 cytoplasmic 408 552 non-cytoplasmic
Input: >AO353_10315 MIAIREAWKAGLLRPEHWLRNIVSGVIVGVVALPLAMAFAIASGVKPEQGIYTAIVSGLL VSLFGGSRLQIAGPTGAFVVILSGVTAKYGVDGLQIATMMAGAILLLLGITKLGAIIKFI PDPVIVGFTAGIGVIIWVGQWKDFFGLPKISGEHFHERLWHLVQALPSFHVPTTLLALSS LVLVITAPKIPGIRRVPGPLIAMVVVTALQAFFQFAGVATIGSAFGGIPQGLPEVGLPAI TLPQVIELIGPAFAIAMLGAIESLLSAVVADGMAGTKHDSNQELIGQGIANLVTPLFGGF AATGAIARTATNIRNGGNSPIAGFVHALTLILLILFLAPLASDIPLCALAAILFVVAYNM SELKHFQRMVKRAPKADVAILLITFSLTVFSDLAIAVNIGVILAMLQFMRRMASSVEVQQ MVEKELEVELRINGHVRLPPGVLVYTIEGPLFFGAAETFERVLAQTHTDPGTLIIRLKRV PFMDITGLQTLLEVIEHLRKRSIVVKLCEANEKVLGKLDKAGILQALGPEHYHADFSGAL GSFEIDKTPHLG
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server